We are live on ! Find out more
ONEM

1Life Healthcare

Delisted

ONEM was delisted on the 21st of February, 2023.

189 hedge funds and large institutions have $1.68B invested in 1Life Healthcare in 2022 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 65 increasing their positions, 64 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed

473% more call options, than puts

Call options by funds: $38.6M | Put options by funds: $6.73M

2% more repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 64

6% less funds holding

Funds holding: 201189 (-12)

28% less first-time investments, than exits

New positions opened: 28 | Existing positions closed: 39

30% less funds holding in top 10

Funds holding in top 10: 107 (-3)

35% less capital invested

Capital invested by funds: $2.59B → $1.68B (-$918M)

Holders
189
Holders Change
-12
Holders Change %
-5.97%
% of All Funds
2.98%
Holding in Top 10
7
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-30%
% of All Funds
0.11%
New
28
Increased
65
Reduced
64
Closed
39
Calls
$38.6M
Puts
$6.73M
Net Calls
+$31.9M
Net Calls Change
+$42.6M
Name Holding Trade Value Shares
Change
Change in
Stake
SIM
51
SRS Investment Management
New York
$1.88M
PA
52
Parallel Advisors
California
$1.78M -$1.11K -99 -0.1%
PPA
53
Parametric Portfolio Associates
Washington
$1.74M +$749K +66,838 +74%
D.E. Shaw & Co
54
D.E. Shaw & Co
New York
$1.71M +$1.72M +153,904 New
State of Wisconsin Investment Board
55
State of Wisconsin Investment Board
Wisconsin
$1.57M +$1.58M +141,356 New
T. Rowe Price Associates
56
T. Rowe Price Associates
Maryland
$1.54M -$2.6M -232,093 -63%
MAM
57
Must Asset Management
South Korea
$1.48M +$30.5K +2,721 +2%
RhumbLine Advisers
58
RhumbLine Advisers
Massachusetts
$1.41M +$38.6K +3,448 +3%
FF
59
Ford Foundation
New York
$1.4M -$706K -63,054 -33%
CM
60
Caption Management
Oklahoma
$1.33M +$1.34M +120,000 New
Vontobel Holding
61
Vontobel Holding
Switzerland
$1.33M +$57.4K +5,129 +4%
JF
62
Jump Financial
Illinois
$1.3M -$496K -44,268 -27%
MCM
63
Moore Capital Management
New York
$1.27M +$1.28M +114,714 New
Squarepoint
64
Squarepoint
New York
$1.2M +$1.21M +108,414 New
BBHC
65
Brown Brothers Harriman & Co
New York
$1.19M
Legal & General Group
66
Legal & General Group
United Kingdom
$1.16M -$1.6M -143,250 -58%
PI
67
PEAK6 Investments
Illinois
$1.11M -$238K -21,216 -17%
Jennison Associates
68
Jennison Associates
New York
$1.1M +$1.11M +99,498 New
Invesco
69
Invesco
Georgia
$1.08M +$559K +49,940 +105%
Jane Street
70
Jane Street
New York
$974K -$750K -66,950 -43%
New York State Common Retirement Fund
71
New York State Common Retirement Fund
New York
$931K -$526 -47 -0.1%
Barclays
72
Barclays
United Kingdom
$925K +$935K +83,448 New
BAM
73
Bullseye Asset Management
Colorado
$918K
PGH
74
Partners Group Holding
Switzerland
$872K +$548K +48,888 +164%
EVM
75
Eaton Vance Management
Massachusetts
$846K +$811K +72,448 +1,879%

ONEM Hedge Fund Activity: Q1 2022 in Review

189 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in 1Life Healthcare (ONEM) for Q1 2022, worth a combined $1.68B — down 35% from $2.59B a quarter earlier.

Sellers outnumbered buyers: 39 funds closed out of ONEM and 28 opened new positions — a net loss of 11 holders — while 64 trimmed existing stakes and 65 added.

The largest buyer was Tiger Global Management, adding an estimated $43.5M. The largest seller was Cadian Capital Management, exiting entirely with an estimated $119M sold.

  • 189 institutional investors held 1Life Healthcare (ONEM) as of Q1 2022, down from 201 in Q4 2021.
  • Funds reported $1.68B of 1Life Healthcare stock for Q1 2022, down 35% quarter-over-quarter.
  • 28 funds opened new 1Life Healthcare positions in Q1 2022 and 39 closed out, a net change of -11 holders.
  • The largest 1Life Healthcare buyer in Q1 2022 was Tiger Global Management, an estimated $43.5M added.
  • The largest 1Life Healthcare seller in Q1 2022 was Cadian Capital Management, an estimated $119M sold.

Based on aggregated 13F filings for Q1 2022.